Literature DB >> 15582140

Liver involvement in cystic fibrosis: primary organ damage or innocent bystander?

Carla Colombo, Pier Maria Battezzati.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15582140     DOI： 10.1016/j.jhep.2004.10.002

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  8 in total

1.  Repression of CFTR activity in human MMNK-1 cholangiocytes induces sulfotransferase 1E1 expression in co-cultured HepG2 hepatocytes.

Authors:  Dongning He; Teresa W Wilborn; Josie L Falany; Li Li; Charles N Falany
Journal:  Biochim Biophys Acta       Date:  2008-09-11

2.  The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity.

Authors:  Romina Fiorotto; Ambra Villani; Antonis Kourtidis; Roberto Scirpo; Mariangela Amenduni; Peter J Geibel; Massimiliano Cadamuro; Carlo Spirli; Panos Z Anastasiadis; Mario Strazzabosco
Journal:  Hepatology       Date:  2016-10-27       Impact factor: 17.425

3.  Acoustic radiation force impulse (ARFI) imaging with Virtual Touch Tissue Quantification in liver disease associated with cystic fibrosis in children.

Authors:  L Monti; M Manco; C Lo Zupone; A Latini; M L D'Andrea; F Alghisi; V Lucidi; P Tomà; L Bonomo
Journal:  Radiol Med       Date:  2012-09-17       Impact factor: 3.469

4.  Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium.

Authors:  Roberto Scirpo; Romina Fiorotto; Ambra Villani; Mariangela Amenduni; Carlo Spirli; Mario Strazzabosco
Journal:  Hepatology       Date:  2015-08-28       Impact factor: 17.425

5.  Transmembrane channel activity in human hepatocytes and cholangiocytes derived from induced pluripotent stem cells.

Authors:  Rodrigo M Florentino; Qin Li; Michael C Coard; Nils Haep; Takashi Motomura; Ricardo Diaz-Aragon; Lanuza A P Faccioli; Sriram Amirneni; Zehra N Kocas-Kilicarslan; Alina Ostrowska; James E Squires; Andrew P Feranchak; Alejandro Soto-Gutierrez
Journal:  Hepatol Commun       Date:  2022-03-15

Review 6.  Liver disease in cystic fibrosis: an update.

Authors:  Giuseppe Fabio Parisi; Giovanna Di Dio; Chiara Franzonello; Alessia Gennaro; Novella Rotolo; Elena Lionetti; Salvatore Leonardi
Journal:  Hepat Mon       Date:  2013-08-14       Impact factor: 0.660

7.  PREVALENCE OF HEPATIC STEATOSIS AMONG CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS AND ITS ASSOCIATION WITH NUTRITIONAL STATUS.

Authors:  Amanda Oliva Gobato; Ana Carolina Junqueira Vasques; Antonio Fernando Ribeiro; Roberto Massao Yamada; Gabriel Hessel
Journal:  Rev Paul Pediatr       Date:  2019-06-19

8.  Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores.

Authors:  Thomas Karlas; Marie Neuschulz; Annett Oltmanns; Andrea Güttler; David Petroff; Hubert Wirtz; Jochen G Mainz; Joachim Mössner; Thomas Berg; Michael Tröltzsch; Volker Keim; Johannes Wiegand
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.